Glaxosmithkline (GSK)
GSK · Health Care · 
United Kingdom
Glaxosmithkline (GSK) is a British company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 1.08%. Anyone who holds an ETF containing Glaxosmithkline also has an indirect stake in the company.
Data and Charts: Glaxosmithkline
Key Data for Glaxosmithkline
Alysly Data Analysis: Glaxosmithkline
Glaxosmithkline Connections
The map shows how Glaxosmithkline connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- United Kingdom Country · domicile
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
- Novo Nordisk A/S Stock · similar ETF exposure
- Smith and Nephew Stock · similar ETF exposure
What ETF Is Glaxosmithkline In?
Glaxosmithkline has very high ETF coverage and is held by 26 of the 104 ETFs we track, which together follow 10 indices. That puts the stock in more ETFs than 94.3% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| SPFS | MSCI World Health Care | 1.08% | €10.84 |
| XDWH | MSCI World Health Care | 1.08% | €10.81 |
| SPYE | MSCI Europe | 0.72% | €7.19 |
| XMEU / XIEE | MSCI Europe | 0.71% | €7.13 |
| IMEA | MSCI Europe | 0.71% | €7.10 |
| X600 / XESU | STOXX Europe 600 | 0.65% | €6.51 |
| EXSA | STOXX Europe 600 | 0.65% | €6.50 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.65% | €6.50 |
| WVAL | MSCI World Value | 0.47% | €4.68 |
| XDEV | MSCI World Value | 0.46% | €4.60 |
| EXUS / EXU1 | MSCI World ex USA | 0.40% | €4.00 |
| XDEQ | MSCI World Quality | 0.25% | €2.48 |
| XDWD / XDWL | MSCI World | 0.11% | €1.07 |
| SWWD | MSCI World | 0.10% | €1.01 |
| SPPW | MSCI World | 0.10% | €1.01 |
| EUNL | MSCI World | 0.10% | €1.00 |
| WIMI | MSCI World IMI | 0.10% | €0.97 |
| SPYY | MSCI ACWI | 0.09% | €0.94 |
| IUSQ | MSCI ACWI | 0.09% | €0.90 |
| SPYI / SPSA | MSCI ACWI IMI | 0.08% | €0.85 |
The last column shows how much of €1,000 in one of these funds goes to Glaxosmithkline, based on each fund's latest holdings list.
US-listed ETFs holding Glaxosmithkline (weight per latest SEC filing): VXUS 0.24%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Glaxosmithkline Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Glaxosmithkline had a weight of 0.26% on Sep 30, 2019 and 0.10% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.27% on Mar 31, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Glaxosmithkline overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Glaxosmithkline
| Stock | Shared ETFs | r |
|---|---|---|
| Glaxosmithkline | – | – |
| Novo Nordisk A/S | 25 | – |
| Smith and Nephew | 25 | – |
 Astrazeneca | 24 | – |
| Straumann Holding | 24 | – |
 Haleon | 23 | – |
| Demant A/S | 23 | – |
| Novartis | 25 | – |
 Imperial Brands | 24 | – |
These stocks reach a portfolio through largely the same funds as Glaxosmithkline. “Shared ETFs” counts the funds that hold both.
